334 First-in-human study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of oral cp-724, 714, a selective, small molecule inhibitor of her2 in patients with advanced cancer
2004 ◽
Vol 2
(8)
◽
pp. 101
◽
Keyword(s):
Keyword(s):